Table 1.
GRS-based analysesb | 2-sample MRf | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MR estimatea | Adjusted by GRS-BMIa,c | Restricted risk scorea,d | MR-Eggerb,e | Weighted median estimatorb | |||||||
Variable (per year) | Cases/Controls | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI |
Age at menarche | 12,944/10,741 | 0.98 | 0.95–1.02 | 0.99 | 0.95–1.02 | 0.99 | 0.95–1.03 | 0.99 | 0.83–1.17 | 1.00 | 0.90–1.11 |
Age at menopause | 12,944/10,741 | 0.98 | 0.94–1.01 | NA | NA | NA | NA | 1.02 | 0.94–1.10 | 1.00 | 0.95–1.05 |
Time period of hormone exposure | 12,944/10,741 | 0.99 | 0.97–1.02 | 0.99 | 0.97–1.02 | 0.99 | 0.97–1.01 | 0.97 | 0.93–1.01 | 1.00 | 0.95–1.05 |
BMI body mass index, CCFR Colon Cancer Family Registry, CI confidence interval, CORECT Colorectal Transdisciplinary study, GECCO Genetics and Epidemiology of Colorectal Cancer Consortium, GRS genetic risk score, MR Mendelian randomisation, NA not applicable, OR odds ratio per year, SNPs single-nucleotide polymorphisms, se standard error
aLogistic regression model adjusted for age, study, and principal components of genetic ancestry
bMeta-analysed estimate of GECCO/CORECT datasets (CCFR centres participated in GECCO or CORECT and were analysed as such)
cAdditionally adjusted for a GRS for BMI out of 77 reported SNPs for BMI36
d42 BMI-associated SNPs were excluded from the age at menarche and time period of oestrogen exposure—risk scores
eEstimate derived from the slope of MR-Egger
fEstimates derived using summary statistics; se for calculation of CI obtained via bootstrapping